Novozymes B receives Investment Bank Analyst Rating Update
- Investing.com
Pro- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Novozymes A/S B (NVZMF)"Novozymes A/S B stock price live, this page displays CSE NSISb stock exchange data. View the NSISb premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Novozymes A/S B real time stock price chart below.
What Is the Novozymes A/S B Stock Price Today?
The Novozymes A/S B stock price today is 58.5000.
What Is the Stock Symbol for Novozymes A/S B?
The stock symbol for Novozymes A/S B is ""NSISb.""
What Stock Exchange Does Novozymes A/S B Trade On?
Novozymes A/S B is listed and trades on the Copenhagen stock exchange.
Is Novozymes A/S B a Good Stock to Buy?
Determining whether Novozymes A/S B—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NSISb quote. (ISIN: DK0060336014)"
What Is the Novozymes A/S B Stock Price Today?
The Novozymes A/S B stock price today is 58.5000.
What Is the Stock Symbol for Novozymes A/S B?
The stock symbol for Novozymes A/S B is ""NSISb.""
What Stock Exchange Does Novozymes A/S B Trade On?
Novozymes A/S B is listed and trades on the Copenhagen stock exchange.
Is Novozymes A/S B a Good Stock to Buy?
Determining whether Novozymes A/S B—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NSISb quote. (ISIN: DK0060336014)"
58.5000
-0.3000(-0.51%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
58.5000
58.5000
52 wk Range
49.8900
71.5180
NVZMF Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
58.500058.5000
52 wk Range
49.890071.5180
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
Unlock(0.48%)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
Unlock(0.48%)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockNVZMF Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Price Target
484.1000
Upside
+17.0172%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
- Novozymes B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Novozymes B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Novozymes B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Novozymes B receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Novozymes B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Novozymes B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Novozymes B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Novozymes B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Novozymes B receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Novozymes A/S B Company Profile
Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novonesis A/S was founded in 1925 and is based in Bagsvaerd, Denmark.
Compare NVZMF to Peers and Sector
Metrics to compare | NVZMF | Sector Sector - Average of metrics from a broad group of related Basic Materials sector companies | Relationship RelationshipNVZMFPeersSector | |
|---|---|---|---|---|
P/E Ratio | 91.1x | 16.7x | −0.2x | |
PEG Ratio | −2.38 | 0.02 | 0.00 | |
Price/Book | 2.3x | 1.6x | 1.6x | |
Price / LTM Sales | 8.5x | 1.3x | 1.3x | |
Upside (Analyst Target) | - | 23.0% | 28.4% | |
Fair Value Upside | Unlock | 14.8% | 2.2% | Unlock |
Dividends
Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.02
Dividend Yield
0.51%
Industry Median 1.58%
Annualized payout
0.2970
Paid unevenly
5-Years Growth
-
Growth Streak
People Also Watch
FAQ
What Is the Novozymes B (NVZMF) Stock Price Today?
The Novozymes B stock price today is 58.50
What Stock Exchange Does Novozymes B Trade On?
Novozymes B is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Novozymes B?
The stock symbol for Novozymes B is "NVZMF."
Does Novozymes B Pay Dividends? What’s The Current Dividend Yield?
The Novozymes A/S B dividend yield is 0.48%.
What Is the Novozymes B Market Cap?
As of today, Novozymes B market cap is 27.26B.
What is Novozymes B Earnings Per Share?
The Novozymes B EPS is 1.02.
From a Technical Analysis Perspective, Is NVZMF a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.